Jonathan Beer

Company: Bristol Myers Squibb

Job title: Senior Director - Diagnostic Sciences, Solid Tumors

Seminars:

Harnessing the Value of ctDNA in Cancer Drug Development 11:20 am

Exploring the developments required for ctDNA to replace traditional tumor biopsies for monitoring treatment response and drug resistance in preclinical trials How can ctDNA be leveraged to identify promising drug candidates early in translational development, informing go/no-go decisions for new therapies? Considering the potential for ctDNA-guided patient stratification in translational studies, what are the ethical…Read more

day: Day One